1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Partner Fund Management, L.P. Buys Stryker Corp, Puma Biotechnology Inc, WellCare Health Plans Inc, Sells Abbott Laboratories, Spark Therapeutics Inc, GoDaddy Inc

San Francisco, CA, based Investment company Partner Fund Management, L.P. buys Stryker Corp, Puma Biotechnology Inc, WellCare Health Plans Inc, Allergan PLC, Pfizer Inc, UnitedHealth Group Inc, Exact Sciences Corp, ICU Medical Inc, PerkinElmer Inc, PTC Therapeutics Inc, IQVIA Holdings Inc, Voyager Therapeutics Inc, Dermira Inc, WAVE Life Sciences, Zimmer Biomet Holdings Inc, NXP Semiconductors NV, Alder BioPharmaceuticals Inc, Aptiv PLC, Netflix Inc, New York Times Co, Live Nation Entertainment Inc, uniQure NV, Sea, Fair Isaac Corp, Agilent Technologies Inc, Molina Healthcare Inc, Fluidigm Corp, Merit Medical Systems Inc, Ctrip.com International, Coherus BioSciences Inc, Splunk Inc, Nevro Corp, iRhythm Technologies Inc, Mirati Therapeutics Inc, Lyft Inc, Zai Lab, Shopify Inc, Sienna Biopharmaceuticals Inc, sells Abbott Laboratories, Spark Therapeutics Inc, GoDaddy Inc, Aerie Pharmaceuticals Inc, BlackRock Inc, Salesforce.com Inc, Amazon.com Inc, DaVita Inc, Alphabet Inc, CME Group Inc, Microsoft Corp, Cigna Corp, AnaptysBio Inc, PayPal Holdings Inc, Solid Biosciences Inc, Cardiovascular Systems Inc, Sage Therapeutics Inc, Allakos Inc, Anthem Inc, Edwards Lifesciences Corp, Blueprint Medicines Corp, Tableau Software Inc, Audentes Therapeutics Inc, Acorda Therapeutics Inc, Kura Oncology Inc, HCA Healthcare Inc, ViewRay Inc, Wright Medical Group NV, Unity Biotechnology Inc, argenx SE, Pivotal Software Inc, Pacira BioSciences Inc, Clementia Pharmaceuticals Inc, Green Dot Corp, ServiceNow Inc, LiveRamp Holdings Inc, Gritstone Oncology Inc, The Madison Square Garden Co, Coupa Software Inc, Dropbox Inc, NuCana PLC, Elastic NV, Avrobio Inc, Accuray Inc, Carbon Black Inc, Neon Therapeutics Inc, Arcus Biosciences Inc, Zscaler Inc, StoneCo, Marinus Pharmaceuticals Inc, Ascendis Pharma A/S, Anaplan Inc, DocuSign Inc, Neuronetics Inc, Liberty Formula One Group, Activision Blizzard Inc, Adobe Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Partner Fund Management, L.P.. As of 2019Q1, Partner Fund Management, L.P. owns 78 stocks with a total value of $3.5 billion. These are the details of the buys and sells.

For the details of Partner Fund Management, L.P.'s stock buys and sells, go to https://www.gurufocus.com/guru/partner+fund+management%2C+l.p./current-portfolio/portfolio

These are the top 5 holdings of Partner Fund Management, L.P.
  1. Arena Pharmaceuticals Inc (ARNA) - 3,255,230 shares, 4.16% of the total portfolio. Shares added by 7.98%
  2. Zimmer Biomet Holdings Inc (ZBH) - 951,246 shares, 3.47% of the total portfolio. Shares added by 40.23%
  3. Pfizer Inc (PFE) - 2,833,096 shares, 3.43% of the total portfolio. Shares added by 203.50%
  4. Stryker Corp (SYK) - 579,444 shares, 3.27% of the total portfolio. New Position
  5. UnitedHealth Group Inc (UNH) - 451,689 shares, 3.19% of the total portfolio. Shares added by 87.51%
New Purchase: Stryker Corp (SYK)

Partner Fund Management, L.P. initiated holding in Stryker Corp. The purchase prices were between $152.46 and $198, with an estimated average price of $179.51. The stock is now traded at around $185.67. The impact to a portfolio due to this purchase was 3.27%. The holding were 579,444 shares as of .

New Purchase: Puma Biotechnology Inc (PBYI)

Partner Fund Management, L.P. initiated holding in Puma Biotechnology Inc. The purchase prices were between $20.35 and $42.37, with an estimated average price of $30.25. The stock is now traded at around $16.59. The impact to a portfolio due to this purchase was 2.88%. The holding were 2,603,920 shares as of .

New Purchase: WellCare Health Plans Inc (WCG)

Partner Fund Management, L.P. initiated holding in WellCare Health Plans Inc. The purchase prices were between $230.61 and $282.5, with an estimated average price of $258.4. The stock is now traded at around $272.85. The impact to a portfolio due to this purchase was 2.56%. The holding were 332,834 shares as of .

New Purchase: Allergan PLC (AGN)

Partner Fund Management, L.P. initiated holding in Allergan PLC. The purchase prices were between $132.09 and $160.79, with an estimated average price of $144.95. The stock is now traded at around $136.71. The impact to a portfolio due to this purchase was 2.4%. The holding were 574,837 shares as of .

New Purchase: Exact Sciences Corp (EXAS)

Partner Fund Management, L.P. initiated holding in Exact Sciences Corp. The purchase prices were between $61.98 and $96.5, with an estimated average price of $84.73. The stock is now traded at around $95.37. The impact to a portfolio due to this purchase was 1.4%. The holding were 566,359 shares as of .

New Purchase: PerkinElmer Inc (PKI)

Partner Fund Management, L.P. initiated holding in PerkinElmer Inc. The purchase prices were between $72.79 and $97.5, with an estimated average price of $89.9. The stock is now traded at around $87.91. The impact to a portfolio due to this purchase was 1.3%. The holding were 472,656 shares as of .

Added: Pfizer Inc (PFE)

Partner Fund Management, L.P. added to a holding in Pfizer Inc by 203.50%. The purchase prices were between $39.53 and $43.65, with an estimated average price of $42.24. The stock is now traded at around $41.15. The impact to a portfolio due to this purchase was 2.3%. The holding were 2,833,096 shares as of .

Added: UnitedHealth Group Inc (UNH)

Partner Fund Management, L.P. added to a holding in UnitedHealth Group Inc by 87.51%. The purchase prices were between $236.02 and $271.13, with an estimated average price of $255.35. The stock is now traded at around $236.08. The impact to a portfolio due to this purchase was 1.49%. The holding were 451,689 shares as of .

Added: ICU Medical Inc (ICUI)

Partner Fund Management, L.P. added to a holding in ICU Medical Inc by 113.28%. The purchase prices were between $221.09 and $253.28, with an estimated average price of $239.82. The stock is now traded at around $225.27. The impact to a portfolio due to this purchase was 1.36%. The holding were 374,860 shares as of .

Added: Zimmer Biomet Holdings Inc (ZBH)

Partner Fund Management, L.P. added to a holding in Zimmer Biomet Holdings Inc by 40.23%. The purchase prices were between $100.43 and $129.56, with an estimated average price of $116.76. The stock is now traded at around $118.55. The impact to a portfolio due to this purchase was 1%. The holding were 951,246 shares as of .

Added: New York Times Co (NYT)

Partner Fund Management, L.P. added to a holding in New York Times Co by 113.39%. The purchase prices were between $21.39 and $34.49, with an estimated average price of $29.46. The stock is now traded at around $33.78. The impact to a portfolio due to this purchase was 0.86%. The holding were 1,727,851 shares as of .

Added: Live Nation Entertainment Inc (LYV)

Partner Fund Management, L.P. added to a holding in Live Nation Entertainment Inc by 443.92%. The purchase prices were between $47.69 and $64.28, with an estimated average price of $56.55. The stock is now traded at around $64.32. The impact to a portfolio due to this purchase was 0.76%. The holding were 514,407 shares as of .

Sold Out: Abbott Laboratories (ABT)

Partner Fund Management, L.P. sold out a holding in Abbott Laboratories. The sale prices were between $66.22 and $80.06, with an estimated average price of $74.34.

Sold Out: Aerie Pharmaceuticals Inc (AERI)

Partner Fund Management, L.P. sold out a holding in Aerie Pharmaceuticals Inc. The sale prices were between $36.1 and $49.25, with an estimated average price of $43.86.

Sold Out: BlackRock Inc (BLK)

Partner Fund Management, L.P. sold out a holding in BlackRock Inc. The sale prices were between $377.98 and $443.77, with an estimated average price of $419.31.

Sold Out: DaVita Inc (DVA)

Partner Fund Management, L.P. sold out a holding in DaVita Inc. The sale prices were between $49.95 and $59.21, with an estimated average price of $55.37.

Sold Out: CME Group Inc (CME)

Partner Fund Management, L.P. sold out a holding in CME Group Inc. The sale prices were between $162.58 and $188.12, with an estimated average price of $177.05.

Sold Out: Cigna Corp (CI)

Partner Fund Management, L.P. sold out a holding in Cigna Corp. The sale prices were between $159.69 and $199.81, with an estimated average price of $183.17.



Here is the complete portfolio of Partner Fund Management, L.P.. Also check out:

1. Partner Fund Management, L.P.'s Undervalued Stocks
2. Partner Fund Management, L.P.'s Top Growth Companies, and
3. Partner Fund Management, L.P.'s High Yield stocks
4. Stocks that Partner Fund Management, L.P. keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK